This was per 10 billion pairs (so 6x cheaper). The specifications are here: https://www.illumina.com/systems/sequencing-platforms/novaseq-x-plus/specifications.html
Metacelsus
Karma: 74
Random adversarial threshold search enables automated DNA screening
Political concerns, not technical challenges, are the main barriers to antimalarial gene drive deployment
US cancels DEEP VZN (project to seek out potential pandemic viruses)
(Posting my LessWrong comment here)
>If you’re paying $8k per billion reads
>This will likely go down: Illumina has recently released the more cost effective NovaSeq X, and as Illumina’s patents expire there are various cheaper competitors.
Indeed it did go down. Recently I paid $13,000 for 10 billion reads (NovaSeq X, Broad Institute; this was for my meiosis project). So sequencing costs can be much lower than $8K/billion.
Illumina is planning to start offering a 25 billion read flowcell for the NovaSeq X in October; I don’t know how much this will cost but I’d guess around $20,000.
ALSO: if you’re trying to detect truly novel viruses, using a Kraken database made from existing viral sequences is not going to work! However, many important threats are variants of existing viruses, so those could be detected (although possibly with lower efficiency).
I’d be happy to provide pro bono consultation on gene drive design. I’ve written previously about the topic here: https://denovo.substack.com/p/will-no-one-rid-me-of-this-turbulent and https://denovo.substack.com/p/gene-drives-why-the-wait